Fan Site: Inspired, Not Endorsed, By Rakesh Jhunjhunwala

Posts tagged Camson Bio-Tech

Dharmesh Kant Recommends “High Quality Proxy Play” Stock With Huge Upside Potential



Dharmesh Kant, now with Motilal Oswal, is diligently discharging his responsibility of identifying winning stocks and recommending them to us. He has now homed in on a top-quality stock which stands to benefit from the demand for specialty chemicals and pharmaceuticals

Check Out Dharmesh Kant’s Latest Stock Pick. Will It Be A Big Winner Like MPS & Force Motors?



Dharmesh Kant’s latest stock pick is a top-quality and well managed company with a long and successful track record. It enjoys a high “entry barrier” and a “moat” and has high return ratios

IndiaNivesh Sells A Truckload Of Camson Bio-Tech Stock. Should We Be Worried?



Today, there was great excitement in the air over the news that IndiaNivesh had sold off a huge chunk of Camson Bio-Tech, a stock earlier recommended by them. Have they lost confidence in the stock and does it spell doom for us?

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 508 other subscribers

RSS Stocks Talk Forum

  • Saurabh Mukherjea has shuffled his PMS portfolios
    Saurabh Mukherjea has shuffled his PMS portfolios. Bajaj Finserv & CMS Info are added to the Kings of Capital portfolio. Ahluwalia Contracts is added to Rising Giants portfolio while Clean Science is added to Little Champs. Eureka Forbes is exited as there is intense competition ... Saurabh Mukherjea has shuffled his PMS portfolios
  • Anant Raj is riding India's data center wave. TP ₹1100 (31%)
    Anant Raj is riding India's data center wave. Multiple growth levers are at play. Strong pre-sales, collections & operational cash flows underpin its growth. Significant revenue, EBITDA margin expansion & long-term value creation expected. TP ₹1100 (31%) Download research report... Anant Raj is riding India's data center wave. TP ₹1100 (31%)
  • Mukul Agrawal's portfolio has 56 stocks valued at ₹7,329 Cr in Dec'24 (vs ₹4,695 Cr in 2023, up +56%
    Mukul Agrawal's portfolio has 56 stocks valued at ₹7,329 Cr in Dec'24 (vs ₹4,695 Cr in 2023, up +56%). 6 stocks ASM, Hind Rectifier, Neuland, LT Foods, Pearl Global & Concord are multibaggers with 100%+ YoY gain. Other big YoY winners are Raghav (97%), PTC (95%) & Nuvama (91%) ... Mukul Agrawal's portfolio has 56 […]
Disclaimer: This is a Fan Site in Rakesh Jhunjhunwala's name. Rakesh Jhunjhunwala is not associated with us and is in no way aware, accountable or responsible for what is stated here. Further, nothing here constiutes investment advice for you to act on. Also, we have a vested interest, and are extremely biased, in everything that we say. So Mind It!